| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/23/2005 | EP1507762A1 Pesticidal pyridinecarboxamide derivatives |
| 02/23/2005 | EP1507761A1 Pyridine carboxamide derivatives and their use as pesticides |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507759A1 Cyanoguanidine produgs |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1140845B1 Susbstituted pyridine herbicides |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP0883612B1 Thiol derivatives with metallopeptidase (ace/nep) inhibitory activity |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585750A Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585743A Process for preparation of alpha-hydroxycarboxylic acid amides |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1583761A Bivalent rare earth complex containing pyridine substituted indene ligand and its use |
| 02/23/2005 | CN1583723A Preparation of 1-(6-methylpyridin-3-yl)-2-(4-methylsulfonyl-phenyl)ethanon |
| 02/23/2005 | CN1190427C Method for preparing pyrimidine derivative |
| 02/23/2005 | CN1190423C Heteroycle derivatives and drugs |
| 02/22/2005 | US6858720 Forming nucleotide bond; obtain nucleotide sequences reaction mixture, contact with the free hydroxyl of a growing polynucleotide, recover nucleic acid |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide |
| 02/22/2005 | US6858631 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858611 Antiarrhythmia agents; cardiovascular disorders |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | US6858600 Used for inhibiting the interaction of an alpha-helical protein with another protein or binding site; for therapy of diseases |
| 02/22/2005 | US6858434 Using thin layer chromatography for rapid preparation and screening of lead structures for drug candidates; rational drug design |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014581A2 Lanthanide complexes preparation and uses thereof |
| 02/17/2005 | WO2005014580A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | WO2005014550A1 3- aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors |
| 02/17/2005 | WO2005014549A1 Process for preparation of 4-aryl-nicotinamide derivatives |
| 02/17/2005 | WO2005014548A1 Process for producing low-melting crystal of free disopyramide base |
| 02/17/2005 | WO2005014547A1 Mixtures of ionic liquids with lewis acids |
| 02/17/2005 | WO2005014545A2 N-′2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2004067489A8 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/17/2005 | WO2004016578A8 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | US20050038248 Chemotherapeutic agents |
| 02/17/2005 | US20050038112 prevention, control and treatment of cancer; leukemia |
| 02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
| 02/17/2005 | US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038080 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 02/17/2005 | US20050038064 Anticarcinogenic agents; breast, colon, lung, prostate, ovarian, and gastric cancers, leukemia, melanomas; (5R)-5-ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038033 use in treating respiratory system disorders such as asthma, incipient asthma and wheezy infant syndrome, chronic or acute bronchoconstriction, chronic bronchitis, small airways obstruction, emphysema, chronic eosinophilic pneumonia, chronic obstructive pulmonary disease, allergies |
| 02/17/2005 | US20050038031 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 02/17/2005 | US20050038028 Hydroxyethylene compounds with asp2 inhibitory activity |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | US20050037918 Non-metallocenes, method for the production thereof and use thereof in the polymerization of olefins |
| 02/17/2005 | US20050037233 Electroluminescent iridium compounds with fluorinated phenylpyridine ligands, and devices made with such compounds |
| 02/17/2005 | DE10339360A1 New 7-amino-5-halo-pyrazolo-(1,5-a)-pyrimidine derivatives, useful as microbicides, especially fungicides or bactericides for protecting plants or materials such as wood |
| 02/17/2005 | DE10333174A1 Verfahren zur Durchführung einer In-Situ-Quench Reaktion A method for performing an in-situ-quench reaction |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534905A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | CA2533698A1 Lanthanide complexes preparation and uses thereof |
| 02/17/2005 | CA2532176A1 New 2-pyridinylethylbenzamide compounds |
| 02/17/2005 | CA2531796A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/16/2005 | EP1506966A2 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystaline structures thereof |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506185A1 Novel compounds and their use |
| 02/16/2005 | EP1506168A2 Gelling agents |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1506162A2 Synthesis of benzonitriles and benzimidates |
| 02/16/2005 | EP1506158A2 Diamino-functional chalcones |
| 02/16/2005 | EP1506157A2 Amino-functional chalcones |
| 02/16/2005 | EP1505966A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 02/16/2005 | EP1505962A2 Monotherapy for the treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s) |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1339675B1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
| 02/16/2005 | EP1296698A4 Therapeutic agents - ii |
| 02/16/2005 | EP1296697A4 Therapeutic agents - i |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
| 02/16/2005 | CN1582285A Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 02/16/2005 | CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
| 02/16/2005 | CN1582275A Calcium antagonistic compound |
| 02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 02/16/2005 | CN1582271A Inhibitors of integrin alpha v beta 6 |
| 02/16/2005 | CN1582154A Method for treating or prophylaxis of aldo sterone-medicated phthogenic effects in subjwect using epoxy-steroidal aldosterone antagonist |
| 02/16/2005 | CN1580046A Process for large-scale preparation of 2-hydroxyethyl pyridine |
| 02/16/2005 | CN1580045A Process for large-scale preparation of 2-vinyl pyridine |
| 02/16/2005 | CN1579628A Olefine oligomerization catalyst, and its preparation method and use |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855850 Method of manufacturing fluorine compounds, and a method of recovering or regenerating precursors of fluorinating agents |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855840 Dithioester chain transfer agents for use in reversible addition fragmentation chain transfer (RAFT) polymerization of acrylamide monomers; low polydispersity |
| 02/15/2005 | US6855831 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent |